The harmonics of rodent pulmonary hypertension models

International Journal of Clinical Practice

Volumn 65, Issue SUPPL. 172, 2011, Pages 1-2

  Voelkel, N F ^a   Gomez Arroyo, J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOREX; BLEOMYCIN; MEDIUM CHAIN TRIACYLGLYCEROL; MONOCROTALINE; SEMAXANIB;

AIRWAY REMODELING; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE MODEL; EDITORIAL; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE FAILURE; HEPATOPULMONARY SYNDROME; HYPERTHYROIDISM; HYPOTHYROIDISM; HYPOXIA; LUNG CIRCULATION; NONHUMAN; PORTOPULMONARY HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RODENT; SYSTOLIC BLOOD PRESSURE; ANIMAL; CAUSE OF DEATH; HUMAN; NOTE;

ANIMALS; CAUSE OF DEATH; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION, PULMONARY;

EID: 84856202690     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02712.x     Document Type: Editorial

References (12)

1. Ryan J, Bloch K, Archer S,. Rodent models of pulmonary hypertension: harmonization with the World Health Organization's categorization of human PH. Int J Clin Pract 2011; 65 (Suppl. 172): 15-34.
2. McLaughlin VV, Archer SL, Badesch DB, et al., ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53: 1573-619.
3. Taraseviciene-Stewart L, Nicolls MR, Kraskauskas D, et al., Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling. Am J Respir Crit Care Med 2007; 175: 1280-9. (Pubitemid 46905754)
4. Biondi B, Kahaly GJ,. Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Rev Endocrinol 2010; 6: 431-43.
5. Bauer NR, Moore TM, McMurtry IF,. Rodent models of PAH: are we there yet? Am J Physiol Lung Cell Mol Physiol 2007; 293: L580-2. (Pubitemid 47358819)
6. Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF,. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol 2009; 297: L1013-32.
7. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, et al., Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2006; 291: L668-76. (Pubitemid 44498478)
8. Sugita T, Hyers TM, Dauber IM, Wagner WW, McMurtry IF, Reeves JT,. Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats. J Appl Physiol 1983; 54: 371-4. (Pubitemid 13153511)
9. Benoist D, Stones R, Drinkhill M, Bernus O, White E,. Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. Am J Physiol Heart Circ Physiol 2011; Epub ahead of print. 11th March 2011.
10. Bogaard HJ, Natarajan R, Henderson SC, et al., Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 2009; 120: 1951-60.
11. Daley E, Emson C, Guignabert C, et al., Pulmonary arterial remodeling induced by a Th2 immune response. J Exp Med 2008; 205: 361-72. (Pubitemid 351281602)
12. Dvorak HF,. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-9. (Pubitemid 17052899)